Composition for ocular topical administration treatment ocular hypertension and glaucoma
OwnerRyuji Ueno, Junichi Kawasaki +1inventors
InventorsRyuji Ueno, Junichi Kawasaki, Tadashi Hayashi
Life of this patent
Estimating the term…
Abstract
The present invention provides a composition for ocular topical administration for treating ocular hypertension and glaucoma, comprising latanoprost as an active ingredient, and (a) a polyol and/or sugar alcohol, (b) a nonionic surface active agent, and (c) an edetic acid compound. The composition of the present invention comprises lower amount of preservatives such as benzalkonium chloride comparative to the conventional product and therefore, can reduce incidence of the adverse side effects caused by the preservatives. In addition, the composition of the present invention can be stored stably at room temperatures for a long term.
Claims14
A composition for ocular topical administration for treating ocular hypertension and glaucoma, comprising latanoprost as an active ingredient and further comprising:
- (a) polyol and/or sugar alcohol,
- (b) nonionic surface active agent, and
- (c) an edetic acid compound.
An improvement of a composition for ocular topical administration comprising latanoprost as an active ingredient for treating ocular hypertension and glaucoma, which comprises supplementing the composition with:
- (a) a polyol and/or a sugar alcohol,
- (b) nonionic surface active agent, and
- (c) an edetic acid compound.
(canceled)
Dependencies are inferred from the claim text.